Clinical Trials
4 trialsNCT04287075 2024-03-26
Rethink Pain
Axogen Corporation
Terminated
NCT02073474 2022-12-20
An Observational Post-Marketing Safety Registry of Sativex®
Jazz Pharmaceuticals
Completed
NCT01236053 2017-07-06
Cancer in Patients With Gabapentin (GPRD)
GlaxoSmithKline
Completed
NCT01138124 2017-05-30
Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD)
GlaxoSmithKline
Completed